Soft Agar Colony Formation Assay for in Vitro Chemotherapy Sensitivity Testing of Human Renal Cell Carcinoma: Mayo Clinic Experience
- 1 February 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 131 (2) , 391-393
- https://doi.org/10.1016/s0022-5347(17)50392-4
Abstract
Different samples of human renal carcinoma (206) were tested for in vitro chemotherapy sensitivity using a soft agar colony formation assay similar to that originally described by Salmon et al. Of 159, 80 (50%) evaluable tumor tests showed colony formation in vitro and gave clinical drug sensitivity information. Two-thirds of tumors were resistant to all drugs tested, despite a median number of drugs tested per tumor of 14.5. Tumors 5 (6%) were remarkably sensitive to numerous anticancer drugs in vitro. The most active drugs found in vitro were teniposide, actinomycin D, bleomycin, hydroxyurea, mitoguanazone dihydrochloride, mitomycin C and L-alanosine. Other drugs tested showed low in vitro cytotoxicity.This publication has 5 references indexed in Scilit:
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Cell aggregates in the soft agar “human tumour stem-cell assay”British Journal of Cancer, 1982
- Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium saltLife Sciences, 1982
- Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapyThe American Journal of Medicine, 1981
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978